Cerhum Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.46M
- Investors
-
3
Cerhum General Information
Description
Developer of a 3D-printed bone graft designed to be used for repairing facial deformities. The company's bone graft helps in reconstruction by using bone-similar materials and 3D designs and offers to replace procedures, taking bone from the patient and non-regenerative materials, enabling healthcare providers to improve patient treatment and comfort by reducing surgery times.
Contact Information
Website
www.cerhum.comCorporate Office
- PIMW B56 - Rue des pôles, 1
- 4000 Liege
- Belgium
Corporate Office
- PIMW B56 - Rue des pôles, 1
- 4000 Liege
- Belgium
Cerhum Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 20-Apr-2022 | $2.46M | Completed | Generating Revenue | ||
| 3. Later Stage VC | 01-Dec-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 09-Aug-2019 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 02-May-2016 | Completed | Startup |
Cerhum Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class B | ||||||||
| Class B | ||||||||
| Class A | ||||||||
| Class B | 960 | $56.88 | $56.88 | 1x | $56.88 | 5.13% | ||
| Class A | 1,960 | $56.88 | $56.88 | 1x | $56.88 | 10.47% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cerhum Patents
Cerhum Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3883501-A1 | Cranial-maxillofacial implant | Active | 22-Nov-2018 | ||
| EP-3883501-B1 | Cranial-maxillofacial implant | Active | 22-Nov-2018 | ||
| EP-3883501-C0 | Cranial-maxillofacial implant | Active | 22-Nov-2018 | ||
| EP-4454614-A2 | Cranial-maxillofacial implant | Inactive | 22-Nov-2018 | ||
| EP-4454614-A3 | Cranial-maxillofacial implant | Inactive | 22-Nov-2018 | A61F2/2875 |
Cerhum Signals
Cerhum Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| W.IN.G | Venture Capital | Minority | ||
| WSL | Accelerator/Incubator | Minority | ||
| Noshaq | Venture Capital | Minority |
Cerhum FAQs
-
When was Cerhum founded?
Cerhum was founded in 2015.
-
Where is Cerhum headquartered?
Cerhum is headquartered in Liege, Belgium.
-
What is the size of Cerhum?
Cerhum has 22 total employees.
-
What industry is Cerhum in?
Cerhum’s primary industry is Therapeutic Devices.
-
Is Cerhum a private or public company?
Cerhum is a Private company.
-
What is the current valuation of Cerhum?
The current valuation of Cerhum is .
-
What is Cerhum’s current revenue?
The current revenue for Cerhum is .
-
How much funding has Cerhum raised over time?
Cerhum has raised $4.12M.
-
Who are Cerhum’s investors?
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process